Prescription drug transparency provisions modifications
SF 3294 modifies prescription drug transparency rules in Minnesota, potentially affecting how drug pricing information is disclosed to patients and healthcare consumers.
SF 3294 modifies prescription drug transparency rules in Minnesota, potentially affecting how drug pricing information is disclosed to patients and healthcare consumers.
WeVote — Public opinion
No community votes yet. Be the first to weigh in from the Vote tab.
Versions
Bill text & amendments
The official bill text and any amendments will be posted here once available.